Related Experiment Videos
Identification and characterization of early glial progenitors using a transgenic selection strategy
K J Chandross1, R I Cohen, P Paras
1National Institutes of Health, National Institute for Neurological Disorders and Stroke, Laboratory of Developmental Neurogenetics, Bethesda, Maryland 20892, USA.
Summary
New transgenic mice allow researchers to track and isolate oligodendrocytes (OLs) and Schwann cells (SCs) from early development. This method uses beta-galactosidase (beta-gal) activity for efficient identification and purification of these crucial glial cells.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Oligodendrocytes (OLs) and Schwann cells (SCs) are vital glial cells responsible for myelination in the central and peripheral nervous systems, respectively.
- Understanding the spatiotemporal development and precise selection of OLs and SCs is crucial for studying neurological development and disease.
- Existing methods for identifying and isolating these cells can be challenging and may not capture early developmental stages.
Purpose of the Study:
- To develop a transgenic mouse model for the simultaneous identification and selection of oligodendrocytes (OLs) and Schwann cells (SCs).
- To define the spatiotemporal development of OLs and SCs using a novel reporter system.
- To establish an efficient method for isolating pure populations of OLs and SCs for further study.
Main Methods:
- Generation of transgenic mice expressing a bacterial beta-galactosidase (beta-gal) and neomycin phosphotransferase fusion protein (betageo) under the control of murine 2'3'-cyclic nucleotide 3'-phosphodiesterase (muCNP) promoters I and II.
- Detection of beta-gal activity in vivo at various developmental stages (embryonic day 12.5 to postnatal day 10) across different neural tissues.
- In vitro culture of cells from transgenic mice in the presence of G418 (antibiotic selection) to isolate and assess the differentiation potential of beta-gal-positive cells.
Main Results:
- Transgenic beta-gal activity was detected early (embryonic day 12.5) in the ventral rhombencephalon, spinal cord, and neural crest, indicating progenitor locations.
- Postnatally, beta-gal activity was specifically localized to OLs in the brain and SCs in the sciatic nerve, absent in other neural cell types.
- Antibiotic selection (G418) of cultured cells from postnatal day 10 brain or sciatic nerve resulted in 99% pure populations of beta-gal-positive OLs or SCs within 8-9 days.
Conclusions:
- The muCNP-betageo transgenic mice serve as a valuable tool for identifying OLs and SCs throughout their lineage development, starting from early glial progenitor stages.
- This novel approach confirms that beta-gal-positive cells identified in vivo are indeed glial progenitors, capable of surviving antibiotic selection and differentiating in vitro.
- The developed experimental paradigm enables rapid and efficient isolation of pure OL and SC populations, highlighting the utility of cell-specific promoters in cell type purification.